Evidence map›Paper›PMID 24034573›Full record

ArticleNutrition research (New York, N.Y.)2013

Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in mice.

Nikki A Ford, Amy C Elsen, John W Erdman

Abstract read
In one paragraph

Article in Nutrition research (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Carotenoids and non-alcoholic fatty liver disease.Hepatobiliary surgery and nutrition · 2015
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nikki A FordDepartment of Nutritional Sciences, University of Texas at Austin, Austin TX 78723, USA.
Amy C Elsen
John W Erdman
University of Illinois Urbana-Champaign · USThe University of Texas at Austin · US

Funding

Tomatoes, Lycopene, and Prostate Carcinogenesis in MiceR01CA125384 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ERDMAN, JOHN W · 2007 to 2011
$1.4M
NCI NIH HHS R01 CA125384
6 · The paper itself

Abstract

Carotene-15,15'-monooxygenase (CMO-I) cleaves β-carotene to form vitamin A, whereas carotene-9',10'-monooxygenase (CMO-II) preferentially cleaves non-provitamin A carotenoids. Recent reports indicate that β-carotene metabolites regulate dietary lipid uptake, whereas lycopene regulates peroxisome proliferator-activated receptor expression. To determine the physiologic consequences of carotenoids and their interactions with CMO-I and CMO-II, we characterized mammalian carotenoid metabolism, metabolic perturbations, and lipid metabolism in female CMO-I(-/-) and CMO-II(-/-) mice fed lycopene or tomato-containing diets for 30 days. We hypothesized that there would be significant interactions between diet and genotype on carotenoid accumulation and lipid parameters. CMO-I(-/-) mice had higher levels of leptin, insulin, and hepatic lipidosis but lower levels of serum cholesterol. CMO-II(-/-) mice had increased tissue lycopene and phytofluene accumulation, reduced insulin-like growth factor 1 levels and cholesterol levels, but elevated liver lipids and cholesterol compared with wild-type mice. The diets did not modulate these genotypic perturbations, but lycopene and tomato powder significantly decreased serum insulin-like growth factor 1. Tomato powder also increased hepatic peroxisome proliferator-activated receptor expression, independent of genotype. These data point to the pleiotropic actions of CMO-I and CMO-II supporting a strong role of these proteins in regulating tissue carotenoid accumulation and the lipid metabolic phenotype as well as tomato carotenoid-independent regulation of lipid metabolism.

Indexed as

DietAdipose TissueAnimalsbeta Carotenebeta-Carotene 15,15'-MonooxygenaseCarotenoidsCholesterolFatty Acid DesaturasesFemaleGenotypeHormonesInflammationInsulin-Like Growth Factor ILipid MetabolismLiverLycopeneBco1 protein, mousebeta Carotenebeta-Carotene 15,15'-Monooxygenasecarotene-9',10'-monooxygenase, mouseCarotenoidsCholesterolFatty Acid DesaturasesHormonesinsulin-like growth factor-1, mouseInsulin-Like Growth Factor ILycopenephytofluenePowdersRNA, Messengercarotene-15,15′-monooxygenasecarotene-9′,10′-monooxygenaseCholesterolCMO-ICMO-IIIGF-1insulin-like growth factor 1LipidsLycopenemessenger RNAMicemRNAperoxisome proliferator-activated receptorPhytoenePPARretinoid X receptorRXRsingle nucleotide polymorphismSNPTomatowild-typeWT

Identifiers

PMID24034573
PMCPMC3804893
OpenAlexW2024570942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.